DOCSLIB.ORG

Mouse Mrgprg Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Mrgprg Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Mrgprg Knockout Project (CRISPR/Cas9) Objective: To create a Mrgprg knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Mrgprg gene (NCBI Reference Sequence: NM_203492 ; Ensembl: ENSMUSG00000050276 ) is located on Mouse chromosome 7. 2 exons are identified, with the ATG start codon in exon 2 and the TAG stop codon in exon 2 (Transcript: ENSMUST00000058092). Exon 2 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 2 starts from about 0.12% of the coding region. Exon 2 covers 100.0% of the coding region. The size of effective KO region: ~865 bp. The KO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 Legends Exon of mouse Mrgprg Knockout region Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of start codon is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of stop codon is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(23.6% 472) | C(26.6% 532) | T(23.9% 478) | G(25.9% 518) Note: The 2000 bp section upstream of start codon is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(25.8% 516) | C(26.0% 520) | T(22.8% 456) | G(25.4% 508) Note: The 2000 bp section downstream of stop codon is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr7 - 143765374 143767373 2000 browser details YourSeq 35 80 150 2000 89.8% chr2 - 37958161 37958230 70 browser details YourSeq 34 132 190 2000 76.8% chr7 + 98332661 98332718 58 browser details YourSeq 33 88 152 2000 92.4% chr8 + 84468181 84468245 65 browser details YourSeq 31 139 197 2000 91.0% chr17 + 93340279 93340336 58 browser details YourSeq 29 139 197 2000 74.6% chr17 - 47257701 47257759 59 browser details YourSeq 29 1225 1255 2000 96.8% chr7 + 63365283 63365313 31 browser details YourSeq 29 139 197 2000 91.5% chr2 + 120547831 120547890 60 browser details YourSeq 29 139 197 2000 74.6% chr1 + 82760758 82760816 59 browser details YourSeq 27 1229 1255 2000 100.0% chr2 - 149791130 149791156 27 browser details YourSeq 27 1227 1259 2000 87.1% chr11 + 110902100 110902131 32 browser details YourSeq 26 1230 1255 2000 100.0% chr3 - 54548828 54548853 26 browser details YourSeq 24 138 161 2000 100.0% chr7 - 132677146 132677169 24 browser details YourSeq 24 88 111 2000 100.0% chr4 - 150609599 150609622 24 browser details YourSeq 24 113 152 2000 80.0% chr2 - 161091879 161091918 40 browser details YourSeq 23 99 125 2000 92.6% chr9 + 7083590 7083616 27 browser details YourSeq 23 72 94 2000 100.0% chr2 + 3773875 3773897 23 browser details YourSeq 23 138 160 2000 100.0% chr18 + 63396574 63396596 23 browser details YourSeq 22 177 198 2000 100.0% chr3 - 102209251 102209272 22 browser details YourSeq 22 474 509 2000 80.6% chr2 + 60414836 60414871 36 Note: The 2000 bp section upstream of start codon is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr7 - 143762507 143764506 2000 browser details YourSeq 65 815 943 2000 78.1% chr13 - 65134722 65134858 137 browser details YourSeq 65 836 941 2000 81.2% chr6 + 97333823 97334228 406 browser details YourSeq 64 835 943 2000 77.9% chr18 - 36815948 36816054 107 browser details YourSeq 62 835 943 2000 77.0% chr8 - 87923972 87924078 107 browser details YourSeq 60 835 930 2000 81.3% chr1 - 156538605 156538700 96 browser details YourSeq 60 835 930 2000 80.5% chr2 + 163470881 163470975 95 browser details YourSeq 59 838 943 2000 76.3% chr13 - 63344248 63344351 104 browser details YourSeq 59 828 928 2000 79.8% chr13 - 30191910 30192015 106 browser details YourSeq 59 834 930 2000 80.5% chr1 - 192556788 192556884 97 browser details YourSeq 59 835 940 2000 78.4% chr7 + 144568000 144568448 449 browser details YourSeq 59 835 943 2000 77.5% chr15 + 80986138 80986243 106 browser details YourSeq 58 835 952 2000 83.8% chr17 - 47103184 47103319 136 browser details YourSeq 58 835 930 2000 80.3% chr11 - 20546585 20546680 96 browser details YourSeq 58 835 930 2000 80.3% chr11 + 51769934 51770029 96 browser details YourSeq 57 830 927 2000 76.1% chr4 - 72717354 72717449 96 browser details YourSeq 57 847 942 2000 76.6% chr3 - 144649784 144649877 94 browser details YourSeq 57 846 930 2000 96.9% chr2 - 147009543 147009908 366 browser details YourSeq 56 835 944 2000 86.9% chr6 - 85936336 85936454 119 browser details YourSeq 56 835 943 2000 74.1% chr5 - 143010418 143010524 107 Note: The 2000 bp section downstream of stop codon is BLAT searched against the genome. No significant similarity is found. Page 5 of 8 https://www.alphaknockout.com Gene and protein information: Mrgprg MAS-related GPR, member G [ Mus musculus (house mouse) ] Gene ID: 381974, updated on 12-Aug-2019 Gene summary Official Symbol Mrgprg provided by MGI Official Full Name MAS-related GPR, member G provided by MGI Primary source MGI:MGI:3033145 See related Ensembl:ENSMUSG00000050276 Gene type protein coding RefSeq status PROVISIONAL Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Mrgg; Gm1098 Expression Biased expression in mammary gland adult (RPKM 5.3), placenta adult (RPKM 1.6) and 4 other tissues See more Orthologs human all Genomic context Location: 7; 7 F5 See Mrgprg in Genome Data Viewer Exon count: 2 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 7 NC_000073.6 (143763710..143766993, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 7 NC_000073.5 (150949615..150952898, complement) Chromosome 7 - NC_000073.6 Page 6 of 8 https://www.alphaknockout.com Transcript information: This gene has 2 transcripts Gene: Mrgprg ENSMUSG00000050276 Description MAS-related GPR, member G [Source:MGI Symbol;Acc:MGI:3033145] Gene Synonyms LOC381974, MrgG Location Chromosome 7: 143,763,710-143,766,993 reverse strand. GRCm38:CM001000.2 About this gene This gene has 2 transcripts (splice variants), 91 orthologues, 21 paralogues and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Mrgprg-201 ENSMUST00000058092.7 1821 289aa ENSMUSP00000060411.6 Protein coding CCDS22045 Q91ZB5 TSL:1 GENCODE basic APPRIS P1 Mrgprg-202 ENSMUST00000208986.1 671 156aa ENSMUSP00000146374.1 Protein coding - A0A140LHD7 CDS 3' incomplete TSL:NA 23.28 kb Forward strand 143.755Mb 143.760Mb 143.765Mb 143.770Mb 143.775Mb Contigs AC158299.7 > Genes (Comprehensive set... < Osbpl5-203protein coding < Mrgprg-201protein coding < Gm44998-201TEC < Mrgprg-202protein coding Regulatory Build 143.755Mb 143.760Mb 143.765Mb 143.770Mb 143.775Mb Reverse strand 23.28 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Non-Protein Coding processed transcript Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000058092 < Mrgprg-201protein coding Reverse strand 3.28 kb ENSMUSP00000060... Transmembrane heli... Low complexity (Seg) Superfamily SSF81321 Prints G protein-coupled receptor, rhodopsin-like Mas-related G protein-coupled receptor family PANTHER Mas-related G protein-coupled receptor family Mas-related G protein-coupled receptor G Gene3D 1.20.1070.10 CDD Mas-related G protein-coupled receptor G All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 40 80 120 160 200 240 289 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Load more

Recommended publications
  • Edinburgh Research Explorer
    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
    [Show full text]
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation
    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
    [Show full text]
  • Rabbit Anti-MRGPRG/FITC Conjugated Antibody-SL17758R
    SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-MRGPRG/FITC Conjugated antibody SL17758R-FITC Product Name: Anti-MRGPRG/FITC Chinese Name: FITC标记的G protein-coupled receptor169抗体 G protein coupled receptor 169; G protein coupled receptor MRGG; G-protein coupled receptor 169; GPR169; Mas related G protein coupled receptor member G; MAS Alias: related GPR member G; Mas-related G-protein coupled receptor member G; MRGG; MRGPRG; MRGRG_HUMAN. Organism Species: Rabbit Clonality: Polyclonal React Species: Human, ICC=1:50-200IF=1:50-200 Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 32kDa Form: Lyophilized or Liquid Concentration: 1mg/ml immunogen: KLH conjugated synthetic peptide derived from human MRGPRG Lsotype: IgG Purification: affinitywww.sunlongbiotech.com purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. background: MRGG is a 289 amino acid multi-pass membrane protein that functions as an orphan receptor. A member of the G-protein coupled receptor 1 family and Mas subfamily, Product Detail: MRGG is implicated in pain sensation and modulation by regulating nociceptor function.
    [Show full text]
  • G Protein-Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. British Journal of Pharmacology (2015) 172, 5744–5869 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors Stephen PH Alexander1, Anthony P Davenport2, Eamonn Kelly3, Neil Marrion3, John A Peters4, Helen E Benson5, Elena Faccenda5, Adam J Pawson5, Joanna L Sharman5, Christopher Southan5, Jamie A Davies5 and CGTP Collaborators 1School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK, 2Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK, 3School of Physiology and Pharmacology, University of Bristol, Bristol, BS8 1TD, UK, 4Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK, 5Centre for Integrative Physiology, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/ 10.1111/bph.13348/full. G protein-coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading.
    [Show full text]
  • G Protein‐Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology (2019) 176, S21–S141 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors Stephen PH Alexander1 , Arthur Christopoulos2 , Anthony P Davenport3 , Eamonn Kelly4, Alistair Mathie5 , John A Peters6 , Emma L Veale5 ,JaneFArmstrong7 , Elena Faccenda7 ,SimonDHarding7 ,AdamJPawson7 , Joanna L Sharman7 , Christopher Southan7 , Jamie A Davies7 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria 3052, Australia 3Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK 4School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 5Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 6Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 7Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website.
    [Show full text]
  • Unlocking the Non-Ige-Mediated Pseudo-Allergic Reaction Puzzle with Mas-Related G-Protein Coupled Receptor Member X2 (MRGPRX2)
    cells Review Unlocking the Non-IgE-Mediated Pseudo-Allergic Reaction Puzzle with Mas-Related G-Protein Coupled Receptor Member X2 (MRGPRX2) Mukesh Kumar, Karthi Duraisamy and Billy-Kwok-Chong Chow * School of Biological Sciences, The University of Hong Kong, Pokfulam Road, Hong Kong, China; [email protected] (M.K.); [email protected] (K.D.) * Correspondence: [email protected]; Tel.: +852-2299-0850; Fax: +852-2559-9114 Abstract: Mas-related G-protein coupled receptor member X2 (MRGPRX2) is a class A GPCR ex- pressed on mast cells. Mast cells are granulated tissue-resident cells known for host cell response, allergic response, and vascular homeostasis. Immunoglobulin E receptor (Fc"RI)-mediated mast cell activation is a well-studied and recognized mechanism of allergy and hypersensitivity reac- tions. However, non-IgE-mediated mast cell activation is less explored and is not well recognized. After decades of uncertainty, MRGPRX2 was discovered as the receptor responsible for non-IgE- mediated mast cells activation. The puzzle of non-IgE-mediated pseudo-allergic reaction is unlocked by MRGPRX2, evidenced by a plethora of reported endogenous and exogenous MRGPRX2 ag- onists. MRGPRX2 is exclusively expressed on mast cells and exhibits varying affinity for many molecules such as antimicrobial host defense peptides, neuropeptides, and even US Food and Drug Administration-approved drugs. The discovery of MRGPRX2 has changed our understanding of mast cell biology and filled the missing link of the underlying mechanism of drug-induced MC degranulation and pseudo-allergic reactions. These non-canonical characteristics render MRGPRX2 Citation: Kumar, M.; Duraisamy, K.; Chow, B.-K.-C.
    [Show full text]
  • Oxygenated Fatty Acids Enhance Hematopoiesis Via the Receptor GPR132
    Oxygenated Fatty Acids Enhance Hematopoiesis via the Receptor GPR132 The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Lahvic, Jamie L. 2017. Oxygenated Fatty Acids Enhance Hematopoiesis via the Receptor GPR132. Doctoral dissertation, Harvard University, Graduate School of Arts & Sciences. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:42061504 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Oxygenated Fatty Acids Enhance Hematopoiesis via the Receptor GPR132 A dissertation presented by Jamie L. Lahvic to The Division of Medical Sciences in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Developmental and Regenerative Biology Harvard University Cambridge, Massachusetts May 2017 © 2017 Jamie L. Lahvic All rights reserved. Dissertation Advisor: Leonard I. Zon Jamie L. Lahvic Oxygenated Fatty Acids Enhance Hematopoiesis via the Receptor GPR132 Abstract After their specification in early development, hematopoietic stem cells (HSCs) maintain the entire blood system throughout adulthood as well as upon transplantation. The processes of HSC specification, renewal, and homing to the niche are regulated by protein, as well as lipid signaling molecules. A screen for chemical enhancers of marrow transplant in the zebrafish identified the endogenous lipid signaling molecule 11,12-epoxyeicosatrienoic acid (11,12-EET). EET has vasodilatory properties, but had no previously described function on HSCs.
    [Show full text]
  • A Panel of DNA Methylation Signature from Peripheral Blood May Predict
    Onwuka et al. BMC Cancer (2020) 20:692 https://doi.org/10.1186/s12885-020-07194-5 RESEARCH ARTICLE Open Access A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility Justina Ucheojor Onwuka, Dapeng Li, Yupeng Liu, Hao Huang, Jing Xu, Ying Liu, Yuanyuan Zhang and Yashuang Zhao* Abstract Background: Differential DNA methylation panel derived from peripheral blood could serve as biomarkers of CRC susceptibility. However, most of the previous studies utilized post-diagnostic blood DNA which may be markers of disease rather than susceptibility. In addition, only a few studies have evaluated the predictive potential of differential DNA methylation in CRC in a prospective cohort and on a genome-wide basis. The aim of this study was to identify a potential panel of DNA methylation biomarkers in peripheral blood that is associated with CRC risk and therefore serve as epigenetic biomarkers of disease susceptibility. Methods: DNA methylation profile of a nested case-control study with 166 CRC and 424 healthy normal subjects were obtained from the Gene Expression Omnibus (GEO) database. The differentially methylated markers were identified by moderated t-statistics. The DNA methylation panel was constructed by stepwise logistic regression and the least absolute shrinkage and selection operator in the training dataset. A methylation risk score (MRS) model was constructed and the association between MRS and CRC risk assessed. Results: We identified 48 differentially methylated CpGs sites, of which 33 were hypomethylated. Of these, sixteen- CpG based MRS that was associated with CRC risk (OR = 2.68, 95% CI: 2.13, 3.38, P < 0.0001) was constructed.
    [Show full text]
  • Mediators and Receptors of Chronic Itch in Primates and Humans
    MEDIATORS AND RECEPTORS OF CHRONIC ITCH IN PRIMATES AND HUMANS A Dissertation Submitted to the Temple University Graduate Board In Partial Fulfillment of the Requirements for the Degree DOCTOR OF PHILOSOPHY by Leigh Ann Nattkemper December 2015 Examining Committee Members: Gil Yosipovitch, MD, Advisory Chair, Department of Dermatology Mary Barbe, PhD, Department of Anatomy and Cell Biology Liselotte Jensen, PhD, Department of Microbiology and Immunology Alan Cowan, PhD, Department of Pharmacology Mark Hoon, PhD, External Member, National Institutes of Health (NIDCR) © Copyright 2015 by Leigh Nattkemper All Rights Reserved ii ABSTRACT Chronic itch has a significant impact on quality of life for millions of patients worldwide, on a level comparable to that of chronic pain. Yet, although there are a host of effective drugs available for pain, there are no therapies that specifically target chronic itch. Current experimental approaches to investigate the pathogenesis of chronic pruritus and to test novel therapeutic agents are largely limited to rodent models. However, rodent models display significant dermatological, neurophysiological, and immunological differences from humans with chronic itch. The disadvantages of the current rodent paradigms call for the design of a valid primate model of chronic itch. For four years, we have monitored scratching behavior in a primate colony (n=35) of Cynomolgus macaques ( Macaca fascicularis ) suffering from idiopathic chronic itch. By comparing molecular and genetic analyses of the primates’ skin to their quantified scratching behavior, we attempted to characterize the underlying mechanisms of chronic itch in this model. Furthermore, the expression of itch-related proteins was examined in both the primate model and in humans with pruritic diseases.
    [Show full text]
  • Identification of the Dog Orthologue of Human MAS-Related G Protein
    www.nature.com/scientificreports OPEN Identifcation of the dog orthologue of human MAS‑related G protein coupled receptor X2 (MRGPRX2) essential for drug‑induced pseudo‑allergic reactions Eri Hamamura‑Yasuno *, Takuma Iguchi, Kazuyoshi Kumagai, Yoshimi Tsuchiya & Kazuhiko Mori MAS‑related G protein coupled receptor‑X2 (MRGPRX2), expressed in human mast cells, is associated with drug‑induced pseudo‑allergic reactions. Dogs are highly susceptible to drug‑induced anaphylactoid reactions caused by various drugs; however, the distribution and physiological function of canine MRGPR family genes, including MRGPRX2, remain largely unknown. In the present study, we clarifed the distribution of dog MRGPR family genes by real‑time quantitative PCR and in situ hybridisation. We also investigated the stimulatory efects of various histamine‑releasing agents, including fuoroquinolones, on HEK293 cells transiently transfected with dog MRGPR family genes to identify their physiological function. Dog MRGPRX2 and MRGPRG were distributed in a limited number of tissues, including the skin (from the eyelid, abdomen, and cheek), whereas MRGPRD and MRGPRF were extensively expressed in almost all tissues examined. Histochemical and in situ hybridisation analyses revealed that MRGPRX2 was expressed in dog connective tissue‑type mast cells in the skin. Intracellular Ca2+ mobilisation assay revealed that HEK293 cells, expressing dog MRGPRX2 or human MRGPRX2, but not dog MRGPRD, MRGPRF, and MRGPRG, responded to histamine‑releasing agents. Our results suggest that dog MRGPRX2 is the functional orthologue of human MRGPRX2 and plays an essential role in drug‑induced anaphylactoid reactions in dogs. Pseudo-allergic drug reactions, including injection-site erythema and swelling, are one of the most commonly observed adverse events associated with intravenous administration of drugs, such as fuoroquinolones, antibac- terial agents, and peptidergic drugs1,2.
    [Show full text]
  • G Protein‐Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology (2019) 176, S21–S141 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors Stephen PH Alexander1 , Arthur Christopoulos2 , Anthony P Davenport3 , Eamonn Kelly4, Alistair Mathie5 , John A Peters6 , Emma L Veale5 ,JaneFArmstrong7 , Elena Faccenda7 ,SimonDHarding7 ,AdamJPawson7 , Joanna L Sharman7 , Christopher Southan7 , Jamie A Davies7 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria 3052, Australia 3Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK 4School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 5Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 6Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 7Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website.
    [Show full text]
  • View / Download 2.1 Mb
    Maternally Inherited Peptides Are Strain Specific Chemosignals That Activate a New Candidate Class of Vomeronasal Chemosensory Receptor by Richard William Roberts University Program in Genetics and Genomics Duke University Date:_______________________ Approved: ___________________________ Hiroaki Matsunami, Supervisor ___________________________ Hubert Amrein ___________________________ Marc Caron ___________________________ Dan Tracey ___________________________ Fan Wang Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the University Program in Genetics and Genomics in the Graduate School of Duke University 2009 ABSTRACT Maternally Inherited Peptides Are Strain Specific Chemosignals That Activate a New Candidate Class of Vomeronasal Chemosensory Receptor by Richard William Roberts University Program in Genetics and Genomics Duke University Date:_______________________ Approved: ___________________________ Hiroaki Matsunami, Supervisor ___________________________ Hubert Amrein ___________________________ Marc Caron ___________________________ Dan Tracey ___________________________ Fan Wang An abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the University Program of Genetics and Genomics in the Graduate School of Duke University 2009 Copyright by Richard William Roberts 2009 Abstract The chemical cues that provide an olfactory portrait of mammalian individuals are in part detected by chemosensory receptors
    [Show full text]